Cargando…
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
Background: Bladder cancer is the most cost-intensive cancer due to high recurrence rates and long follow-up times. Bladder cancer organoids were considered interesting tools for investigating better methods for the detection and treatment of this cancer. Methods: Organoids were generated from uroth...
Autores principales: | Geng, Ruizhi, Harland, Niklas, Montes-Mojarro, Ivonne A., Fend, Falko, Aicher, Wilhelm K., Stenzl, Arnulf, Amend, Bastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141653/ https://www.ncbi.nlm.nih.gov/pubmed/35628262 http://dx.doi.org/10.3390/ijms23105453 |
Ejemplares similares
-
Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation
por: Harland, Niklas, et al.
Publicado: (2022) -
Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems
por: Wei, Yi, et al.
Publicado: (2022) -
Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients
por: Walz, Simon, et al.
Publicado: (2023) -
A Protocol for Organoids from the Urine of Bladder Cancer Patients
por: Walz, Simon, et al.
Publicado: (2023) -
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2022)